Viret Jean-Frederic 4
4 · NGM BIOPHARMACEUTICALS INC · Filed Dec 4, 2023
Insider Transaction Report
Form 4
Viret Jean-Frederic
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-12-01+450,000→ 450,000 totalExercise: $0.77Exp: 2033-11-30→ Common Stock (450,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest over a four-year period commencing November 3, 2023, with 1/4th of the shares vesting on November 3, 2024 and 1/48th of the shares vesting monthly thereafter.